Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

COMPARATIVE ANALYSIS OF CYP3A EXPRESSION IN HUMAN LIVER SUGGESTS ONLY A MINOR ROLE FOR CYP3A5 IN DRUG METABOLISM

Anna Westlind-Johnsson, Sarah Malmebo, Anna Johansson, Charlotta Otter, Tommy B. Andersson, Inger Johansson, Robert J. Edwards, Alan R. Boobis and Magnus Ingelman-Sundberg
Drug Metabolism and Disposition June 2003, 31 (6) 755-761; DOI: https://doi.org/10.1124/dmd.31.6.755
Anna Westlind-Johnsson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Malmebo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Johansson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charlotta Otter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tommy B. Andersson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Inger Johansson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert J. Edwards
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan R. Boobis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Magnus Ingelman-Sundberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 31 no. 6 755-761
DOI 
https://doi.org/10.1124/dmd.31.6.755
PubMed 
12756208

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received January 2, 2003
  • Accepted March 11, 2003
  • Published online June 1, 2003.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Anna Westlind-Johnsson 1 ,
  2. Sarah Malmebo 1 ,
  3. Anna Johansson,
  4. Charlotta Otter,
  5. Tommy B. Andersson,
  6. Inger Johansson,
  7. Robert J. Edwards,
  8. Alan R. Boobis and
  9. Magnus Ingelman-Sundberg
  1. Division of Molecular Toxicology, Institute of Molecular Medicine, Karolinska Institutet, Stockholm, Sweden (A.W-J., S.M., I.J., M.I-S.); Drug Metabolism and Pharmacokinetics & BAC (T.B.A.), and Molecular Biology (A.J., C.O.), AstraZeneca Mölndal Research & Development, Mölndal, Sweden; and Section on Clinical Pharmacology, Division of Medicine, Imperial College, London, United Kingdom (R.J.E., A.R.B.)
  1. Address correspondence to:
    Magnus Ingelman-Sundberg, Division of Molecular Toxicology, IMM, Karolinska Institutet, Box 210, SE-171 77 Stockholm, Sweden. E-mail: maging{at}ki.se
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: May 2003 to July 2022

AbstractFullPdf
May 200399145227
Jun 200344123150
Jul 2003197581
Aug 2003196445
Sep 2003196840
Oct 2003125037
Nov 2003153831
Dec 2003104931
Jan 2004265740
Feb 2004154729
Mar 2004148944
Apr 2004174937
May 2004206325
Jun 2004266061
Jul 2004174329
Aug 2004234437
Sep 2004305947
Oct 2004226251
Nov 2004306736
Dec 2004225032
Jan 2005347138
Feb 2005236033
Mar 2005164941
Apr 200524230
May 200583443
Jun 2005163827
Jul 2005163326
Aug 200592515
Sep 200582720
Oct 200594125
Nov 2005173121
Dec 2005143427
Jan 2006122713
Feb 2006103927
Mar 200693719
Apr 200651714
May 200662211
Jun 200692713
Jul 2006121113
Aug 200651617
Sep 2006194032
Oct 200672216
Nov 20069349
Dec 20066257
Jan 200752415
Feb 200742321
Mar 200792620
Apr 200753119
May 200742731
Jun 200761517
Jul 200772120
Aug 2007122015
Sep 200791019
Oct 2007132830
Nov 200772216
Dec 200711815
Jan 200881013
Feb 200831516
Mar 200831614
Apr 200871513
May 200818912
Jun 200871813
Jul 20087129
Aug 200815197
Sep 2008111115
Oct 20081696
Nov 2008171417
Dec 2008101411
Jan 200973224
Feb 2009122616
Mar 2009111312
Apr 2009211817
May 20096138
Jun 20097915
Jul 2009151612
Aug 2009151512
Sep 2009162015
Oct 2009121112
Nov 2009964
Dec 20091167
Jan 2010101312
Feb 201010138
Mar 2010201422
Apr 201093010
May 2010142312
Jun 20104146
Jul 2010151512
Aug 2010141611
Sep 2010171510
Oct 201051210
Nov 201081511
Dec 20107179
Jan 201171314
Feb 201171810
Mar 2011161712
Apr 2011151522
May 2011121716
Jun 2011151516
Jul 2011241712
Aug 2011301019
Sep 2011281325
Oct 2011171625
Nov 2011301115
Dec 2011181423
Jan 2012231418
Feb 201232199
Mar 2012392530
Apr 2012312324
May 2012343030
Jun 2012221517
Jul 2012441832
Aug 2012332519
Sep 2012331112
Oct 2012242923
Nov 2012232415
Dec 2012311618
Jan 2013252521
Feb 2013254117
Mar 2013293514
Apr 2013454822
May 2013443519
Jun 201316910
Jul 20132989
Aug 201323711
Sep 201345189
Oct 2013361914
Nov 201318125
Dec 201327169
Jan 20143058
Feb 20143596
Mar 201426711
Apr 2014251614
May 2014261310
Jun 2014271010
Jul 2014231216
Aug 20141655
Sep 20141999
Oct 20141789
Nov 20142097
Dec 20143079
Jan 201516810
Feb 201521117
Mar 201524128
Apr 2015181310
May 201530146
Jun 2015322521
Jul 2015191520
Aug 20151647
Sep 2015202011
Oct 201516107
Nov 2015151313
Dec 201523411
Jan 20162288
Feb 201625810
Mar 2016241026
Apr 2016151313
May 2016291310
Jun 2016191715
Jul 2016271613
Aug 2016231317
Sep 2016171513
Oct 201681715
Nov 201610157
Dec 201653014
Jan 201773516
Feb 201732018
Mar 20173253
Apr 2017884
May 20173133
Jun 2017194
Jul 201721312
Aug 201762514
Sep 201742926
Oct 201744313
Nov 201745614
Dec 20172237
Jan 20186197
Feb 201834113
Mar 201834329
Apr 201805623
May 201804824
Jun 20181329
Jul 201822115
Aug 20181209
Sep 201812814
Oct 201872824
Nov 201863215
Dec 201836125
Jan 20192421
Feb 20192864
Mar 20192133
Apr 20192342
May 20192075
Jun 20191312
Jul 20194831
Aug 20192543
Sep 20192584
Oct 20191752
Nov 20192257
Dec 201935152
Jan 20201932
Feb 20202810
Mar 20202251
Apr 20201583
May 2020680
Jun 20203943
Jul 20201815
Aug 2020922
Sep 20203422
Oct 20203852
Nov 20201962
Dec 20202601
Jan 202134384
Feb 202114334
Mar 20213752
Apr 20213330
May 202120130
Jun 202135181
Jul 20213461
Aug 202117203
Sep 202126110
Oct 20212650
Nov 20213541
Dec 20213964
Jan 20222460
Feb 20223521
Mar 20225352
Apr 202211155
May 20221561
Jun 20225334
Jul 2022100

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 31 (6)
Drug Metabolism and Disposition
Vol. 31, Issue 6
1 Jun 2003
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
COMPARATIVE ANALYSIS OF CYP3A EXPRESSION IN HUMAN LIVER SUGGESTS ONLY A MINOR ROLE FOR CYP3A5 IN DRUG METABOLISM
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

COMPARATIVE ANALYSIS OF CYP3A EXPRESSION IN HUMAN LIVER SUGGESTS ONLY A MINOR ROLE FOR CYP3A5 IN DRUG METABOLISM

Anna Westlind-Johnsson, Sarah Malmebo, Anna Johansson, Charlotta Otter, Tommy B. Andersson, Inger Johansson, Robert J. Edwards, Alan R. Boobis and Magnus Ingelman-Sundberg
Drug Metabolism and Disposition June 1, 2003, 31 (6) 755-761; DOI: https://doi.org/10.1124/dmd.31.6.755

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

COMPARATIVE ANALYSIS OF CYP3A EXPRESSION IN HUMAN LIVER SUGGESTS ONLY A MINOR ROLE FOR CYP3A5 IN DRUG METABOLISM

Anna Westlind-Johnsson, Sarah Malmebo, Anna Johansson, Charlotta Otter, Tommy B. Andersson, Inger Johansson, Robert J. Edwards, Alan R. Boobis and Magnus Ingelman-Sundberg
Drug Metabolism and Disposition June 1, 2003, 31 (6) 755-761; DOI: https://doi.org/10.1124/dmd.31.6.755
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Improved CYP Reaction Phenotyping
  • Multiple-Concentration Chemical Inhibition Design
  • New Dog P450 3A98 in Gut
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics